LVIS NeuroMatch— 510(k) K222450

Substantially Equivalent

LVIS Corporation

FDA 510(k) clearance K222450 for LVIS NeuroMatch, Substantially Equivalent on 2023-06-09. Applicant: LVIS Corporation. Device class: 2.

Clearance details

Applicant: LVIS Corporation
Product code: Code OMB
Device class: Class 2
Regulation: 21 CFR 882.1400
Advisory panel: Neurology
Date received: 2022-08-15
Decision date: 2023-06-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Palo Alto, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code OMB

K260998 — Ceribell Neurology Review Software2026-06-24
K252070 — Ceribell Infant Seizure Detection Software2025-11-21
K252160 — Persyst 15 EEG Review and Analysis Software (Persyst 15 (P15))2025-10-31
K241589 — Ceribell Seizure Detection Software2025-04-09
K243743 — autoSCORE (V 2.0.0)2025-04-09

More clearances from LVIS Corporation

K250239 — NeuroMatch2025-05-23
K241390 — NeuroMatch2024-11-26

Data sourced from openFDA. This site is unofficial and independent of the FDA.